Denmark · Delayed Price · Currency is DKK Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of DKK 1.38 trillion. The enterprise value is 1.45 trillion.
| Market Cap | 1.38T |
| Enterprise Value | 1.45T |
Important Dates
The last earnings date was Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Aug 15, 2025 |
Share Statistics
Novo Nordisk has 4.44 billion shares outstanding. The number of shares has decreased by -0.46% in one year.
| Current Share Class | 3.37B |
| Shares Outstanding | 4.44B |
| Shares Change (YoY) | -0.46% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 30.02% |
| Float | 3.19B |
Valuation Ratios
The trailing PE ratio is 13.33 and the forward PE ratio is 12.57. Novo Nordisk's PEG ratio is 1.49.
| PE Ratio | 13.33 |
| Forward PE | 12.57 |
| PS Ratio | 4.38 |
| PB Ratio | 8.14 |
| P/TBV Ratio | 21.83 |
| P/FCF Ratio | 20.95 |
| P/OCF Ratio | 11.17 |
| PEG Ratio | 1.49 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.69, with an EV/FCF ratio of 21.99.
| EV / Earnings | 13.98 |
| EV / Sales | 4.60 |
| EV / EBITDA | 8.69 |
| EV / EBIT | 9.44 |
| EV / FCF | 21.99 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.60.
| Current Ratio | 0.78 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 0.61 |
| Debt / FCF | 1.53 |
| Interest Coverage | 19.21 |
Financial Efficiency
Return on equity (ROE) is 71.46% and return on invested capital (ROIC) is 42.81%.
| Return on Equity (ROE) | 71.46% |
| Return on Assets (ROA) | 21.11% |
| Return on Invested Capital (ROIC) | 42.81% |
| Return on Capital Employed (ROCE) | 55.29% |
| Revenue Per Employee | 4.02M |
| Profits Per Employee | 1.32M |
| Employee Count | 77,349 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 1.22 |
Taxes
In the past 12 months, Novo Nordisk has paid 28.14 billion in taxes.
| Income Tax | 28.14B |
| Effective Tax Rate | 21.33% |
Stock Price Statistics
The stock price has decreased by -58.86% in the last 52 weeks. The beta is 0.35, so Novo Nordisk's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -58.86% |
| 50-Day Moving Average | 348.68 |
| 200-Day Moving Average | 434.61 |
| Relative Strength Index (RSI) | 41.02 |
| Average Volume (20 Days) | 6,803,234 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of DKK 315.60 billion and earned 103.77 billion in profits. Earnings per share was 23.33.
| Revenue | 315.60B |
| Gross Profit | 263.33B |
| Operating Income | 153.65B |
| Pretax Income | 131.91B |
| Net Income | 103.77B |
| EBITDA | 165.49B |
| EBIT | 153.65B |
| Earnings Per Share (EPS) | 23.33 |
Balance Sheet
The company has 32.58 billion in cash and 101.21 billion in debt, giving a net cash position of -68.63 billion or -15.45 per share.
| Cash & Cash Equivalents | 32.58B |
| Total Debt | 101.21B |
| Net Cash | -68.63B |
| Net Cash Per Share | -15.45 |
| Equity (Book Value) | 169.90B |
| Book Value Per Share | 38.23 |
| Working Capital | -52.48B |
Cash Flow
In the last 12 months, operating cash flow was 123.78 billion and capital expenditures -57.81 billion, giving a free cash flow of 65.97 billion.
| Operating Cash Flow | 123.78B |
| Capital Expenditures | -57.81B |
| Free Cash Flow | 65.97B |
| FCF Per Share | 14.85 |
Margins
Gross margin is 83.44%, with operating and profit margins of 48.69% and 32.88%.
| Gross Margin | 83.44% |
| Operating Margin | 48.69% |
| Pretax Margin | 41.80% |
| Profit Margin | 32.88% |
| EBITDA Margin | 52.44% |
| EBIT Margin | 48.69% |
| FCF Margin | 20.90% |
Dividends & Yields
This stock pays an annual dividend of 11.65, which amounts to a dividend yield of 3.75%.
| Dividend Per Share | 11.65 |
| Dividend Yield | 3.75% |
| Dividend Growth (YoY) | 17.68% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 49.88% |
| Buyback Yield | 0.46% |
| Shareholder Yield | 4.20% |
| Earnings Yield | 7.51% |
| FCF Yield | 4.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Novo Nordisk has an Altman Z-Score of 6.16 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.16 |
| Piotroski F-Score | 4 |